The subcellular locations of pl5(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2

Genes and Development

Volumn 11, Issue 4, 1997, Pages 492-503

  Reynisdóttir, Inga ^a   Massagué, Joan ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

cdk inhibitors; cyclin D cdk4 6; p151(Ink4b); p27(Kip1); subcellular location

Indexed keywords

CYCLIN D1; CARRIER PROTEIN; CDK2 PROTEIN, HUMAN; CDK4 PROTEIN, HUMAN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; PROTEIN P16INK4A; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELLULAR DISTRIBUTION; ENZYME INHIBITION; LUNG ALVEOLUS EPITHELIUM; MAMMAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; TANDEM REPEAT; ANIMAL; CELL DIVISION; CELL FRACTIONATION; CELL LINE; DRUG ANTAGONISM; HUMAN; METABOLISM; MINK; PROTEIN BINDING;

MAMMALIA;

ANIMALS; CARRIER PROTEINS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MINK; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SUBCELLULAR FRACTIONS; TUMOR SUPPRESSOR PROTEINS;

EID: 0030614715     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.4.492     Document Type: Article

References (51)

1. Attisano, L., J. Cárcamo, F. Ventura, F.M.B. Weis, J. Massagué, and J.L. Wrana. 1993. Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75: 671-680.
2. 1. Genes Dev 7: 812-821.
3. Bates, S., D. Parry, L. Bonetta, K. Vousden, C. Dickinson, and G. Peters. 1994. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 9: 1633-1640.
4. Bresnahan, W.A., I. Boldogh, T. Ma, T. Albrecht, and E.A. Thompson. 1996. Cyclin E/Cdk2 activity is controlled by different mechanisms in the Go and G1 phases of the cell cycle. Cell Growth Differ 7: 1283-1290.
5. Cárcamo, J., F.M.B. Weis, F. Ventura, R. Wieser, J.L. Wrana, L. Attisano, and J. Massagué. 1994. Type I receptors specify growth inhibitory and transcripitonal responses to TGF-β and activin. Mol. Cell Biol. 14: 3810-3821.
6. Desai, D., Y. Gu, and D.O. Morgan. 1992. Activation of human cyclin-dependent kinases in vitro. Mol. Biol. Cell 3: 571-582.
7. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
8. El-Deiry, W.S., J.W. Harper, P.M. O'Connor, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Burrell, D.E. Hill, Y. Wang, K.G. Wiman, W.E. Mercer, M.B. Kastan, K.W. Kohn, S.J. Elledge, K.W. Kinzler, and B. Vogelstein. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54: 1169-1174.
9. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271: 499-502.
10. Gossen, M. and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. 89: 5547-5551.
11. Guan, K.-L., C.W. Jenkins, Y. Li, M.A. Nichols, X. Wu, C.L. O'Keefe, A.G. Matera, and Y. Xiong. 1994. Growth suppression by p18, a p16INK4/MTS1 and p14INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes & Dev. 8: 2939-2952.
12. Halevy, O., E.G. Novitch, B.D. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
13. Hall, M. and G. Peters. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res. 68: 67-108.
14. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
15. CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16: 859-867.
16. Harlow, E. and D. Lane. Antibodies: A laboratory handbook. 1988. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
17. Heald, R., M. McLoughlin, and F. McKeon. 1993. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 74: 463-474.
18. Henglein, B., X. Chenivesse, J. Wang, D. Eick, and C. Bréchot. 1994. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc. Natl. Acad. Sci. 91: 5490-5494.
19. Kipl accumulation during the cell cycle. Science 271: 1861-1864.
20. Hengst, L., V. Dulic, J.M. Slingerland, E. Lees, and S.I. Reed. 1994. A cell cycle-regulated inhibitor of cyclin dependent kinases. Proc. Natl. Acad. Sci. 91: 5291-5295.
21. Hirai, H., M.F. Roussel, J.-Y. Kato, R.A. Ashmun, and C.J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672-2681.
22. Jeffrey, P.D., A.A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massagué, and N.P. Pavletich. 1995. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376: 313-320.
23. Kipl) of cyclin-dependent kinase-4 activation. Cell 79: 487-496.
24. Laiho, M., J.A. DeCaprio, J.W. Ludlow, D.M. Livingston, and J. Massagué. 1990. Growth inhibition by TGF-β1 linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185.
25. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Dev. 9: 639-649.
26. Kipl in neurons. Proc. Natl. Acad. Sci. 93: 3259-3263.
27. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes & Dev. 10: 142-153.
28. Cip1. Nature 375: 159-161.
29. PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71: 323-334.
30. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell Biol. 14: 2066-2076.
31. Meyerson, M. and E. Harlow. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14: 2077-2086.
32. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
33. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-573.
34. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
35. INK4/MTS1 tumour suppressor gene product. EMBO J. 14: 503-511.
36. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes & Dev. 8: 9-22.
37. Kip1 a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
38. Poon, R.Y.C., H. Toyoshima, and T. Hunter. 1995. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6: 1197-1213.
39. Reynisdóttir, I., K. Polyak, A. Iavarone, and J. Massagué. 1995. Kip/Cip and Ink4 Cdk inhibitor cooperate to induce cell cycle arrest in response to TGF-β. Genes & Dev. 9: 1831-1845.
40. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382: 325-331.
41. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
42. 1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
43. Slingerland, J.M., L. Hengst, C. Pan, D. Alexander, M. Stampfer, and S.I. Reed. 1994. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14: 3683-3694.
44. Soos, T.J., H. Kiyokawa, J.S. Yan, M.S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, and A. Koff. 1996. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7: 135-146.
45. Steinman, R.A., B. Huffman, A. Iro, C. Guillouf, D.A. Liebermann, and M.E. El-Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396.
46. Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes & Dev. 10: 1491-1502.
47. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
48. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269: 1281-1284.
49. Xiong, Y., T. Connolly, B. Futcher, and D. Beach. 1991. Human D-type cyclin. Cell 65: 691-699.
50. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes & Dev. 7: 1572-1583.
51. Zhu, X., M. Ohtsubo, R.M. Bohmer, J.M. Roberts, and R.K. Assoian. 1996. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133: 391-403.